In a report published Friday, Morgan Stanley analyst Vipin Khare reiterated an Overweight rating on Genpact Limited G, but removed the $21.00 price target.
In the report, Morgan Stanley noted, “Genpact reported a mixed set of Dec13 quarter results. Revenues and adj net income were ahead of our expectations, but adj EBIT was marginally lower than our estimate. However, the company gave very disappointing 2014e guidance.”
Genpact Limited closed on Thursday at $17.04.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in